DOI: 10.36347/sjams.2013.v01i06.0050

Pages: 873-877

The aim of the presented study was to evaluate the efficacy of Uterine Artery Embolisation(UAE) as primary therapy intreating symptom aticuterine fibroids. We treated 80 patients in the age group of 19 to 45 year with symptoms of menorrhagia, dysmenorrhea, dyspareunia and pressure symptoms i.e., frequent urination, constipation, pelvic pain by UAE over period of 3 years. Bilateral uterine arteries were embolised in all patients from single groin approach using 5 Fr slip catheter RUC catheter (Robertson uterine artery catheter).Follow up ultrasound was done to assess the decrease in size of fibroid and uterus at 3, 6, 9 and 12 months interval. Better Health Related Quality of Life(HRQOL) was observed in 95% of patients. Bulk related symptoms showed improvements in 92.5 % patient at 12 months. Fibroid volume was reduced around 40% in 3 month, 60% in 6 month & 72% at one year follow up in 95%patients.Average uterine volume reduction was 30% at 3 month and around 46% at 12 month follow up. In conclusion UAE is a reasonable option for women, who wish to preserve their uterus, avoid surgery and prolonged recovery period. UAE has low complication rate, high clinical outcome and high patient satisfaction rates.